• CIBC Run for the Cure

    Thank you to everyone who participated in and supported this year’s Run.


    Read more

  • Vote Couture for the Cure®

    Vote today for your favourite White Cashmere Collection® student design and you could WIN* a $1000 Ultimate Cashmere® Shopping Spree! For every vote, Cashmere® Bathroom Tissue will donate $1 to support the breast cancer cause.


    Enter Now!

  • About Our Merger

    On February 1, 2017, the Canadian Cancer Society (CCS) and the Canadian Breast Cancer Foundation (CBCF) joined forces.


    Learn More

  • Don’t Miss, BRA Day

    Breast Reconstruction Awareness Day is a FREE, annual event that brings leading breast reconstruction experts and women who have been through it together to answer all your questions.


    Learn More

  • You Are Not Alone

    Whether you are living with metastatic breast cancer or have a loved one who is, it can be helpful to talk with someone who understands what you are going through. We are available to you.


    Learn More

  • Breast Cancer Screening

    Need help understanding breast cancer screening and what you should do? We created an online decision aid tool to help inform all women of the factors to consider and their options. Give it a try.


    Try this tool

  • Questions related to breast cancer?

    Our team has the latest information about breast cancer and can answer questions about a diagnosis, treatments, what to expect, financial resources, coping, local support groups and more.


    Learn More

  • Canadian Cancer Statistics 2017

    Canadian Cancer Statistics 2017 was released on June 20. This annual publication gives detailed statistics for the most common types of cancer.


    Learn More

You Are Here :
Home | Ontario | Your Dollars At Work | Research Saves Lives | Research Saves Lives

Upcoming Events

Hot Topics

Corporate Partners & Sponsors

Could a drug that has been used in Canada for over 40 years prevent the recurrence of breast cancer?

Dr. Wendy Parulekar Dr. Wendy Parulekar

This is the question that Dr. Wendy Parulekar, from Queen’s University, and an international team of researchers are trying to answer. Since 2011, CBCF – Ontario has invested almost $900,000 in a large international trial of over 3,500 patients to determine whether metformin – a safe and inexpensive drug long used to treat type II diabetes – can reduce breast cancer recurrence and improve survival in women with early-stage breast cancer.

Researchers have previously discovered a link between how glucose (sugar) and insulin are processed in the body and the risk of breast cancer recurrence. Until now, this link has not been tested in a large group of patients with early-stage breast cancer, but has been observed in studies of people with diabetes who may or may not have cancer, and in animals. This groundbreaking study will demonstrate whether metformin could be an option for women diagnosed with early-stage breast cancer (with or without diabetes) that will reduce their risk of recurrence and prolong their lives.

“The study, built on extensive research by Canadian researchers, is an opportunity to save lives with a drug that is inexpensive, safe and already on the market,” explains Dr. Wendy Parulekar.

The final study results are expected in 2017. In just a few years, we’ll know if metformin is as beneficial as the research suggests it is. If it is, the finding could change how breast cancer is treated globally.

About the Grant:

Canadian Breast Cancer Foundation – Ontario Region’s Research Project Grants program funds laboratory and pre-clinical investigations, clinical research, psychosocial, cancer control, survivorship, quality of life, and other breast cancer research projects. Proposed studies may include participatory, community-based methodologies. Individual projects may be for up to five years (new in 2014). Funding for each project may not exceed $150,000 per year and $450,000 in total.

Area of Focus: Treatment

Information about the Research Team:

  • Dr. Wendy Parulekar is a Medical Oncologist and Physician Coordinator for the NCIC Clinical Trials Group at Queen’s University in Kingston

  • Dr. Pam Goodwin is a Medical Oncologist at Women’s College Hospital and Mount Sinai Hospital, the Director of the Breast Program and Marvelle Koffler Breast Centre at Mount Sinai Hospital, and a Professor at the University of Toronto

  • Dr. Bingshu Chen is a Biostatistician and Assistant Professor at Queen’s University in Kingston

  • Dr. Lois Shepherd is a Pathologist at the Cancer Research Institute and Professor at Queen’s University in Kingston

  • Dr. Timothy Whelan is a Radiation Oncologist at the Juravinski cancer Centre in Hamilton, a Professor at McMaster University in Hamilton, and a Canada Research Chair in Breast Cancer Clinical Trials

  • Dr. Karen Gelmon is a Medical Oncologist and the Clinical Head of Advanced Therapeutics at the BC Cancer Agency, and a Professor at the University of British Columbia

  • Dr. Kathy Pritchard is a Medical Oncologist at the Sunnybrook Odette Cancer Centre in Toronto and a Professor at both the University of Toronto and McMaster University in Hamilton

  • Dr. Vuk Stambolic is a Senior Scientist at the Ontario Cancer Institute in Toronto, and an Associate Professor at the University of Toronto